Metabolic Bone Diseases in the Pediatric Population

Valentina Testini; Laura Eusebi; Umberto Tupputi; Francesca Anna Carpagnano; Francesco Bartelli; Giuseppe Guglielmi

doi:10.1055/s-0040-1722566

Seminars in Musculoskeletal Radiology, Table of Contents

Semin Musculoskelet Radiol 2021; 25(01): 094-104
DOI: 10.1055/s-0040-1722566

Review Article

Metabolic Bone Diseases in the Pediatric Population

Authors

Valentina Testini

¹Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy
Laura Eusebi

²Radiology Unit, “Carlo Urbani” Hospital, Jesi, Italy
Umberto Tupputi

¹Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy
Francesca Anna Carpagnano

¹Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy
Francesco Bartelli

²Radiology Unit, “Carlo Urbani” Hospital, Jesi, Italy
Giuseppe Guglielmi

¹Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy

³Radiology Unit, Barletta University Campus UNIFG, “Dimiccoli” Hospital, Barletta, Italy

Abstract

Bone plays an important role in regulating mineral balance in response to physiologic needs. In addition, bone is subject to a continuous remodeling process to maintain healthy bone mass and growth. Metabolic bone diseases are a heterogeneous group of diseases caused by abnormalities of bone mass, mineral structure homeostasis, bone turnover, or bone growth. In pediatrics, several significant advances have been made in recent years in the diagnosis of metabolic bone diseases (e.g., osteogenesis imperfecta, hyperparathyroidism, rickets, renal osteodystrophy, pediatric osteoporosis, and osteopetrosis). Imaging is fundamental in the diagnosis of these pathologies.

Keywords

bone metabolism - osteogenesis imperfecta - hyperparathyroidism - rickets - pediatric osteoporosis

Full Text

References

References
1 Malcolm AJ. Metabolic bone disease. Curr Diagn Pathol 2002; 8 (01) 19-25
2 Beyens G, Van Hul W. Pathophysiology and genetics of metabolic bone disorders characterized by increased bone turnover. Crit Rev Eukaryot Gene Expr 2007; 17 (03) 215-240
3 Jilka RL. Biology of the basic multicellular unit and the pathophysiology of osteoporosis. Med Pediatr Oncol 2003; 41 (03) 182-185
4 Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem 2010; 285 (33) 25103-25108
5 Gómez-Alonso C. Paediatric metabolic bone disease: a lifetime ahead. Adv Ther 2020; 37 (Suppl. 02) 38-46
6 Forlino A, Marini JC. Osteogenesis imperfecta. Lancet 2016; 387 (10028): 1657-1671
7 Marini JC, Reich A, Smith SM. Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 2014; 26 (04) 500-507
8 Barnes AM, Chang W, Morello R. et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 2006; 355 (26) 2757-2764
9 Harrington J, Sochett E, Howard A. Update on the evaluation and treatment of osteogenesis imperfecta. Pediatr Clin North Am 2014; 61 (06) 1243-1257
10 Cohen JS. Patterns of inheritance in osteogenesis imperfecta. In: Shapiro JR, Byers PH, Glorieux FH, Sponseller PD. eds. Osteogenesis Imperfecta: A Translational Approach to Brittle Bone Disease. New York, NY: Elsevier; 2013: 99
11 Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesis imperfecta—variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser 1979; 15 (5B) 113-129
12 Willing MC, Deschenes SP, Scott DA. et al. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994; 55 (04) 638-647
13 Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014; 164A (06) 1470-1481 Published correction appears in Am J Med Genet A 2015;167A(5):1178
14 El Demellawy D, Davila J, Shaw A, Nasr Y. Brief review on metabolic bone disease. Acad Forensic Pathol 2018; 8 (03) 611-640
15 Glorieux FH, Rauch F, Plotkin H. et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000; 15 (09) 1650-1658
16 Laine CM, Joeng KS, Campeau PM. et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med 2013; 368 (19) 1809-1816
17 Kang H, Aryal A C S, Marini JC. Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia. Transl Res 2017; 181: 27-48
18 Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 2017; 24 (06) 381-388
19 Fotiadou AN, Calleja M, Hargunani R, Keen R. Skeletal manifestations of osteogenesis imperfecta. Semin Musculoskelet Radiol 2016; 20 (03) 279-286
20 Ben Amor IM, Roughley P, Glorieux FH, Rauch F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res 2013; 28 (09) 2001-2007
21 Zionts LE, Moon CN. Olecranon apophysis fractures in children with osteogenesis imperfecta revisited. J Pediatr Orthop 2002; 22 (06) 745-750
22 Rauch F, Plotkin H, Zeitlin L, Glorieux FH. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res 2003; 18 (04) 610-614
23 Chang CY, Rosenthal DI, Mitchell DM, Handa A, Kattapuram SV, Huang AJ. Imaging findings of metabolic bone disease. Radiographics 2016; 36 (06) 1871-1887
24 Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 2000; 163 (02) 184-187
25 Bhadada SK, Bhansali A, Dutta P, Behera A, Chanukya GV, Mittal BR. Characteristics of primary hyperparathyroidism in adolescents. J Pediatr Endocrinol Metab 2008; 21 (12) 1147-1153
26 Starker LF, Akerström T, Long WD. et al. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer 2012; 3 (1-2): 44-51
27 Roizen J, Levine MA. Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc 2012; 75 (09) 425-434
28 Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL. Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993; 13 (02) 357-379
29 Fraser WD. Hyperparathyroidism. Lancet 2009; 374 (9684): 145-158
30 Treglia G, Annunziata S, Pizzuto DA, Giovanella L, Prior JO, Ceriani L. Detection rate of ¹⁸F-labeled PSMA PET/CT in biochemical recurrent prostate cancer: a systematic review and a meta-analysis. Cancers (Basel) 2019; 11 (05) 710
31 Cristina EV, Alberto F. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018; 32 (06) 861-875
32 Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med 2011; 365 (25) 2389-2397 Published correction appears in N Engl J Med 2012;366(22):2138
33 Pitt MJ. Rickets and osteomalacia are still around. Radiol Clin North Am 1991; 29 (01) 97-118
34 Berry JL, Davies M, Mee AP. Vitamin D metabolism, rickets, and osteomalacia. Semin Musculoskelet Radiol 2002; 6 (03) 173-182
35 Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 2009; 27 (04) 392-401
36 Allgrove J, Shaw NJ. A practical approach to vitamin D deficiency and rickets. Endocr Dev 2015; 28: 119-133
37 Mughal MZ, Salama H, Greenaway T, Laing I, Mawer EB. Lesson of the week: florid rickets associated with prolonged breast feeding without vitamin D supplementation. BMJ 1999; 318 (7175): 39-40
38 Whyte MP. Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2016; 12 (04) 233-246
39 Mornet E. Hypophosphatasia. Metabolism 2018; 82: 142-155
40 Bangura A, Wright L, Shuler T. Hypophosphatasia: current literature for pathophysiology, clinical manifestations, diagnosis, and treatment. Cureus 2020; 12 (06) e8594
41 Resnick D. The sclerotic vertebral body. JAMA 1983; 249 (13) 1761-1763
42 Tejwani NC, Schachter AK, Immerman I, Achan P. Renal osteodystrophy. J Am Acad Orthop Surg 2006; 14 (05) 303-311
43 Goodman WC, Coburn JW, Slatopolsky E, Salusky IB, Quarles LD. Renal osteodystrophy in adults and children. In: Favus M. ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3th ed.. Washington, DC: American Society for Bone and Mineral Research; 2003: 341-360
44 Kemper MJ, van Husen M. Renal osteodystrophy in children: pathogenesis, diagnosis and treatment. Curr Opin Pediatr 2014; 26 (02) 180-186
45 Moorthi RN, Moe SM. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int 2013; 84 (05) 886-894
46 Torres A, Lorenzo V, Gonzalez-Posada JM. Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron 1986; 44 (04) 282-287
47 Lima EM, Goodman WG, Kuizon BD. et al. Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol 2003; 18 (06) 554-559
48 Denburg MR, Tsampalieros AK, de Boer IH. et al. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab 2013; 98 (05) 1930-1938
49 Jamal SA, Gilbert J, Gordon C, Bauer DC. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006; 21 (04) 543-548
50 Vierucci F, Saggese G, Cimaz R. Osteoporosis in childhood. Curr Opin Rheumatol 2017; 29 (05) 535-546
51 Marrani E, Giani T, Simonini G, Cimaz R. Pediatric osteoporosis: diagnosis and treatment considerations. Drugs 2017; 77 (06) 679-695
52 Ward LM, Konji VN, Ma J. The management of osteoporosis in children. Osteoporos Int 2016; 27 (07) 2147-2179
53 Williams KM. Update on bone health in pediatric chronic disease. Endocrinol Metab Clin North Am 2016; 45 (02) 433-441
54 Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007; 18 (10) 1319-1328
55 Gordon CM, Leonard MB, Zemel BS. International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 2014; 17 (02) 219-224 . Published correction appears in J Clin Densitom 2014;17(4):517
56 Bachrach LK, Gordon CM. SECTION ON ENDOCRINOLOGY. Bone densitometry in children and adolescents. Pediatrics 2016; 138 (04) e20162398
57 Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8 (09) 1137-1148
58 Bacon S, Crowley R. Developments in rare bone diseases and mineral disorders. Ther Adv Chronic Dis 2018; 9 (01) 51-60
59 Stoker DJ. Osteopetrosis. Semin Musculoskelet Radiol 2002; 6 (04) 299-305
60 Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis 2009; 4: 5